Digital Health
The healthcare, pharma and life sciences industries are universally relevant and have a profound impact on people’s lives globally. However, developed economies face structural challenges like ageing populations, chronic illnesses and reducing government subsidies, while developing economies seek to improve access to quality care and population life expectancy. Pharma giants are seeking to improve research efficiency and improve output of new therapies. Beyond traditional healthcare, next-generation digital wellness is unlocking lifestyle benefits through a preventive approach that has resonated particularly amongst millennials. Technology and increased digitisation are seen as the holy grail to transform the healthcare and life sciences ecosystem.
Arma has quickly established a leadership position in digital health, having advised on several landmark transactions. The role of technology in dictating how we prevent illnesses, improve outcomes, schedule treatments and receive care will only grow. The insatiable appetite of investors and acquirers in this ecosystem is set to power the digital health revolution over the coming decades.
- $5.4 billion aggregate deal value
- 73% cross-border deals
- 21x EBITDA multiple on average
Sub-segment coverage and team
- Healthcare IT (primary, acute and post-acute)
- Healthcare imaging and lab automation
- Patient engagement and telemedicine
- Analytics and population health management
- PharmaTech
- Digital Therapeutics and personalised medicine
- Tech-enabled services for Life Sciences
- Wellness and fitness devices and services
-
Paul-Noël Guély
Managing Partner, London
-
Varun Sunderraman
Partner, London
-
Daniel Fugmann
Partner
-
Dani Abdallah
Director